Skip to Main Content

Brakepoint is a genome-scale discovery engine for the next generation of cancer-immunotherapy drug targets. The best checkpoint drugs work by cutting the "brakes" off a patient's own T cells — but only a handful of those brakes have ever been drugged, and most patients still don't respond. Brakepoint goes looking for the rest, across the whole genome. WHAT I BUILT. A fully reproducible pipeline that reads a public 2,638,736-cell, genome-wide human CD4+ T-cell CRISPRi Perturb-seq screen (Marson lab, Gladstone Institutes; 12,449 gene knockdowns) and, for every knockdown, asks two questions at once: how hard did switching the gene off hit the cell (a coverage-equalized energy-distance effect size), and which way did it push the cell — toward a stronger "fighter" (effector) state or a weaker (exhausted) one (a signed direction axis: a 16-gene effector program minus a 13-gene exhaustion program). WHAT I FOUND. At 2.6M cells, ~97.5% of knockdowns clear significance, so p-values can no longer rank targets — and ranking by raw effect size points straight at essential machinery (18 of the top 20 hits are genes the T cell needs to survive, including its own TCR-signaling core). Adding the signed axis fixes this: it separates a candidate brake from essential machinery. With zero prior hints, Brakepoint rediscovered CBLB — a brake already advancing through clinical trials (NX-1607, HST-1011) — then surfaced four more candidates: CD5, DGKA, SMAD3, and UBASH3A, each scored across seven independent lines of evidence (causal effect, direction, donor consistency, screen fitness, target tractability, immune genetics, and clinical precedent). WHY IT MATTERS. Recovering a target the industry already drugs — blind, from raw data — validates the method; the other four are concrete, testable hypotheses for the next experiment. Brakepoint is a blueprint for AI-native target discovery: one person, one week, on public data, with every result a versioned artifact carrying its exact code and reasoning trail. LINKS. Live project + interactive explorer: https://duanchengchen-oss.github.io/brakepoint/deliverables/ | Open-source code (MIT): https://github.com/duanchengchen-oss/brakepoint | Methods deep-dive: https://github.com/duanchengchen-oss/brakepoint/blob/main/pipeline/METHODS.md

Team

Sam_Duan

Placement

Participant

More from Built with Claude: Life Sciences

What I built. Lazarus is an agent that takes a dead research repository that is open, cited, and no longer runnable, and turns it back into a callable…

DoctorDean project preview

Diffuse midline glioma is a paediatric brainstem cancer that is almost uniformly fatal: about ninety percent of children die within two years, and the first…

Faith Ogundimu project preview

Hippocampus AI is the memory and reasoning engine for scientific discovery. Every experiment generates valuable knowledge, but that knowledge becomes…

Disruptors project preview

I used Claude to train a protein language model that can generate an extremophilic version of any enzyme, maintaining its function, while allowing it to…

Jaymin project preview

Many primates are sexually dichromatic — males and females are different colors. I wanted to know how that trait is built genetically, and how it evolved…

www.loom.com/…

About Trialign is a patient-facing clinical trial matcher for oncology. A patient pastes a clinical note, uploads a record, or connects their EHR via SMART on…

Trialign project preview